Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2002 4
2003 4
2004 2
2005 5
2006 2
2007 3
2008 7
2009 4
2010 2
2011 6
2012 9
2013 13
2014 5
2015 7
2016 14
2017 11
2018 5
2019 7
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Results by year
Filters applied: . Clear all
Page 1
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial.
Zannad F, Greenberg B, Cleland JG, Gheorghiade M, van Veldhuisen DJ, Mehra MR, Anker SD, Byra WM, Fu M, Mills RM. Zannad F, et al. Eur J Heart Fail. 2015 Jul;17(7):735-42. doi: 10.1002/ejhf.266. Epub 2015 Apr 27. Eur J Heart Fail. 2015. PMID: 25919061 Free PMC article. Clinical Trial.
Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Abdelhamid A, Davey Smith G. Hooper L, et al. Cochrane Database Syst Rev. 2015 Jun 10;(6):CD011737. doi: 10.1002/14651858.CD011737. Cochrane Database Syst Rev. 2015. PMID: 26068959 Updated. Review.
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, Thomas L, Wojdyla DM, Hanna M, Keltai M, Steg PG, De Caterina R, Wallentin L, van Gilst WH. Westenbrink BD, et al. Am Heart J. 2017 Mar;185:140-149. doi: 10.1016/j.ahj.2016.12.008. Epub 2016 Dec 22. Am Heart J. 2017. PMID: 28267467 Free article.
Analysis of preventability of stroke-related maternal death from the nationwide registration system of maternal deaths in Japan.
Katsuragi S, Tanaka H, Hasegawa J, Nakamura M, Kanayama N, Nakata M, Murakoshi T, Yoshimatsu J, Osato K, Tanaka K, Sekizawa A, Ishiwata I, Ikeda T; ; on behalf of the Maternal Death Exploratory Committee in Japan and Japan Association of Obstetricians and Gynecologists. Katsuragi S, et al. J Matern Fetal Neonatal Med. 2018 Aug;31(16):2097-2104. doi: 10.1080/14767058.2017.1336222. Epub 2017 Jun 14. J Matern Fetal Neonatal Med. 2018. PMID: 28610468
Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
Chung S, Kim TH, Uhm JS, Cha MJ, Lee JM, Park J, Park JK, Kang KW, Kim J, Park HW, Choi EK, Kim JB, Kim CS, Lee YS, Shim J, Joung B. Chung S, et al. Am J Cardiol. 2020 Jan 1;125(1):68-75. doi: 10.1016/j.amjcard.2019.09.035. Epub 2019 Oct 10. Am J Cardiol. 2020. PMID: 31699363 Clinical Trial.
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S, Granger CB, Held C, Wallentin L, Alexander JH, Lopes RD. Garcia DA, et al. Am Heart J. 2020 Mar;221:1-8. doi: 10.1016/j.ahj.2019.10.013. Epub 2019 Oct 31. Am Heart J. 2020. PMID: 31896036 Clinical Trial.
98 results
Jump to page